Market Closed -
OTC Markets
12:52:00 2024-05-13 pm EDT
5-day change
1st Jan Change
0.0006
USD
0.00%
-33.33%
-80.00%
Bloomios, Inc. Announces Selection as the Exclusive Cannabidiol Product Manufacturer for DRYWORLD
March 31, 2022 at 04:40 pm EDT
Bloomios, Inc. has been selected as the exclusive cannabidiol (CBD) product manufacturer for DRYWORLD. DRYWORLD engaged Bloomios to co-develop and produce the company's branded, high-bioavailability CBD product line especially formulated for athletes. The initial lineup comprises seven products featuring hemp-derived CBD, including gel capsules, tinctures, powdered drinks, heat gels and pain-relief creams: CBD Repair + Recovery Gel Capsule - 750 mg; CBD Tincture - 1500mg; CBD Complete Hydration powdered drink crystals - 150mg; CBD Complete Recovery powdered drink crystals - 375mg; CDB Complete Pre-Workout powdered drink crystal - 750mg; CBD Muscle Heat Gel - 3000mg; CBD Pain Relief Cream - 1000mg.
The new DRYWORLD CBD products are based on all natural ingredients, premium CBD extracts, and are packed with vitamins, minerals, and herbs.
Involuntary Petition Filed Against Bloomios, Inc.
Apr. 15
CI
Bloomios, Inc. Ceases Manufacturing At the Facility and Terminated All Employees
Mar. 08
CI
Bloomios, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 20
CI
Bloomios, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-21
CI
Bloomios, Inc. Provides Revenue Guidance for the Second Quarter of 2023
23-06-01
CI
Bloomios, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-18
CI
Bloomios, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
23-04-17
CI
Bloomios, Inc. Auditor Raises 'Going Concern' Doubt
23-04-16
CI
Bloomios, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-21
CI
Bloomios, Inc. announced that it has received $0.852941 million in funding
22-11-14
CI
Bloomios, Inc. Closes on an Offering of the Debentures
22-10-31
CI
Bloomios, Inc. acquired Infusionz, LLC from Upexi, Inc. for $23.5 million.
22-10-26
CI
Bloomios, Inc. announced that it has received $2.083958 million in funding
22-10-25
CI
Bloomios, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
22-08-22
CI
Bloomios, Inc. to Develop and Produce New Range of Private-Label Products Utilizing, Ashwagandha, Melatonin, Kratom, Lion's Mane, Valerian Root, Reishi Mushroom and Other Natural Ingredients
22-08-04
CI
Bloomios Expands Production Capacity by 300%, Setting Stage for Strong Growth in 2022
22-05-18
CI
Bloomios, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-13
CI
Earnings Flash (BLMS) BLOOMIOS Posts Q4 Revenue $1.7M
22-04-19
MT
Bloomios, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
22-04-15
CI
Bloomios, Inc. Auditor Raises 'Going Concern' Doubt
22-04-14
CI
Bloomios, Inc. Announces Selection as the Exclusive Cannabidiol Product Manufacturer for DRYWORLD
22-03-31
CI
Bloomios, Inc. announced that it has received $0.25 million in funding
21-12-02
CI
Bloomios, Inc. announced that it expects to receive $0.25 million in funding
21-11-29
CI
Bloomios, Inc. Provides Earnings Guidance for the Year 2021
21-11-17
CI
Bloomios, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
21-11-15
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Bloomios, Inc. manufactures, markets, and distributes hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States, through its wholly owned subsidiary, Bloomios Private Label (BPL). BPL is engaged in the manufacturing, processing, sourcing and distribution of hemp-derived, nootropic and nutraceutical products to wholesalers and retailers. The Company manufactures hemp infused products ranging from human edibles, pet edibles, liquid consumables such as tinctures and shots, topicals, and smokable hemp. It provides support at each step from custom formulation, order fulfillment, and brand development. Its product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages and pet treats. It offers its private-label and white-label customers a collections of customizable hemp products that includes over 80 products across seven categories in addition to custom formulation and manufacturing services.
More about the company
1st Jan change
Capi.
-80.00% 40.72K -.--% 339M +35.05% 279M +45.93% 190M +156.53% 145M -35.62% 133M +43.74% 130M -42.86% 96.7M +15.38% 100M +10.00% 33.14M
Medical Farming
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
BLOOMIOS, INC. 
